Beautiful Korea Co., Ltd. to enter overseas market with hyaluronic acid (HA) Ammi filler for anti-aging
Beautiful Korea exported $ 1.6 million worth of hyaluronic acid (HA) Ammi filler for anti-aging
Ammi Aqua filler
Ammi filler is a favorite product which many domestic plastic surgeons and dermatologists prefer due to its affordable price and high quality and it is rapidly expanding its influence in the domestic filler market. However, Ammi filler is known more as a famous brand overseas than in Korea. As Beautiful Korea obtained the GMP certification when established and acquired CE certification and a filler export license from the Ministry of Food and Drug Safety for overseas markets, Beautiful Korea has been exporting Ammi filler products to Chinese, Southeast Asian, and European markets.
NMC technology (Nano Mesh Cross-linking) is used for Ammi filler, which is differentiated from other companies who produce hyaluronic acid fillers. Because of its high viscosity, cohesion, and nano particle size, it maintains its shape for a long time after the treatment. It can be safely used because there is no change in the chemical properties of hyaluronic acid.
Furthermore, it has a stable molecular structure and excellent hydrophilicity, which is a good advantage aiding its volumizing effect. In addition to cross-linking technology, which is used to commercialize hyaluronic acid extracted from bacteria, NMC technology is a technique for reducing particles to ultrafine size through repeated micro-processing.
Beautiful Korea, which is promoting anti-aging and natural beauty regeneration as its corporate value, plans to develop various bio-origin materials through continuous research and development. They revealed their ambitions to challenge the functional cosmetics field in addition to solidifying their position in the field of fillers.
Website: http://www.bkfiller.com
Contact
Beautiful Korea
Choi Chang Nam, Vice President
Send Email
This news is a press release provided by Beautiful Korea Co.,Ltd.. Korea Newswire follows these editorial guidelines.
